Korean Journal of Radiology

The Korean Society of Radiology (대한영상의학회)
권호 표지
DOI QR코드

DOI QR Code

Metastatic Mature Teratoma and Growing Teratoma Syndrome in Patients with Testicular Non-Seminomatous Germ Cell Tumors

  • Daniel B. Green (Department of Radiology, Weill Cornell Medicine) ;
  • Francisco G. La Rosa (Department of Pathology, University of Colorado School of Medicine) ;
  • Paul G. Craig (Department of Radiology, University of Colorado School of Medicine) ;
  • Francesca Khani (Department of Pathology & Laboratory Medicine, Weill Cornell Medicine) ;
  • Elaine T. Lam (Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, UCHealth Tony Grampsas Urologic Cancer Care Clinic, Anschutz Medical Campus)
  • Received : 2020.11.25
  • Accepted : 2021.05.10
  • Published : 2021.10.01
Download PDF
⟨ Previous Next ⟩

Abstract

Metastatic mature teratoma is a common radiologic and histopathologic finding after chemotherapy for metastatic non-seminomatous germ cell tumors. The leading theory for these residual tumors is the selective chemotherapy resistance of teratomas versus the high chemotherapy sensitivity of the embryonal components. Growing teratoma syndrome is a relatively rare phenomenon defined as an enlarging residual mass histologically proven to be a mature teratoma in the setting of normal serum tumor markers. Metastatic mature teratomas should be resected because of their malignant potential and occasional progression to growing teratoma syndrome with the invasion of the surrounding structures. CT is the preferred imaging modality for post-chemotherapy surveillance and should cover all sites of potential metastatic disease. This article reviews the clinical, pathologic, and multimodality imaging features of metastatic mature teratomas in patients with primary testicular non-seminomatous germ cell tumors.

Keywords

References

  1. DiSaia PJ, Saltz A, Kagan AR, Morrow CP. Chemotherapeutic retroconversion of immature teratoma of the ovary. Obstet Gynecol 1977;49:346-350
  2. Logothetis CJ, Samuels ML, Trindade A, Johnson DE. The growing teratoma syndrome. Cancer 1982;50:1629-1635 https://doi.org/10.1002/1097-0142(19821015)50:8<1629::AID-CNCR2820500828>3.0.CO;2-1
  3. Gilligan T, Lin DW, Aggarwal R, Chism D, Cost N, Derweesh IH, et al. Testicular cancer, version 2.2020, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 2019;17:1529-1554 https://doi.org/10.6004/jnccn.2019.0058
  4. Steyerberg EW, Keizer HJ, Fossa SD, Sleijfer DT, Toner GC, Schraffordt Koops H, et al. Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: multivariate analysis of individual patient data from six study groups. J Clin Oncol 1995;13:1177-1187 https://doi.org/10.1200/JCO.1995.13.5.1177
  5. Daneshmand S, Albers P, Fossa SD, Heidenreich A, Kollmannsberger C, Krege S, et al. Contemporary management of postchemotherapy testis cancer. Eur Urol 2012;62:867-876 https://doi.org/10.1016/j.eururo.2012.08.014
  6. Oldenburg J, Alfsen GC, Lien HH, Aass N, Waehre H, Fossa SD. Postchemotherapy retroperitoneal surgery remains necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses. J Clin Oncol 2003;21:3310-3317 https://doi.org/10.1200/JCO.2003.03.184
  7. Shayegan B, Carver BS, Stasi J, Motzer RJ, Bosl GJ, Sheinfeld J. Clinical outcome following post-chemotherapy retroperitoneal lymph node dissection in men with intermediate- and poor-risk nonseminomatous germ cell tumour. BJU Int 2007;99:993-997 https://doi.org/10.1111/j.1464-410X.2007.06740.x
  8. Carver BS, Shayegan B, Serio A, Motzer RJ, Bosl GJ, Sheinfeld J. Long-term clinical outcome after postchemotherapy retroperitoneal lymph node dissection in men with residual teratoma. J Clin Oncol 2007;25:1033-1037 https://doi.org/10.1200/JCO.2005.05.4791
  9. Maroto P, Tabernero JM, Villavicencio H, Mesia R, Marcuello E, Sole-Balcells FJ, et al. Growing teratoma syndrome: experience of a single institution. Eur Urol 1997;32:305-309 https://doi.org/10.1159/000480830
  10. Paffenholz P, Pfister D, Matveev V, Heidenreich A. Diagnosis and management of the growing teratoma syndrome: a single-center experience and review of the literature. Urol Oncol 2018;36:529.e23-529.e30
  11. Kikawa S, Todo Y, Minobe S, Yamashiro K, Kato H, Sakuragi N. Growing teratoma syndrome of the ovary: a case report with FDG-PET findings. J Obstet Gynaecol Res 2011;37:926-932 https://doi.org/10.1111/j.1447-0756.2010.01439.x
  12. Sonneveld DJ, Sleijfer DT, Koops HS, Keemers-Gels ME, Molenaar WM, Hoekstra HJ. Mature teratoma identified after postchemotherapy surgery in patients with disseminated nonseminomatous testicular germ cell tumors: a plea for an aggressive surgical approach. Cancer 1998;82:1343-1351 https://doi.org/10.1002/(SICI)1097-0142(19980401)82:7<1343::AID-CNCR18>3.0.CO;2-6
  13. van der Gaast A, Kok TC, Splinter TA. Growing teratoma syndrome successfully treated with lymphoblastoid interferon. Eur Urol 1991;19:257-258 https://doi.org/10.1159/000473633
  14. Andre F, Fizazi K, Culine S, Droz J, Taupin P, Lhomme C, et al. The growing teratoma syndrome: results of therapy and long-term follow-up of 33 patients. Eur J Cancer 2000;36:1389-1394 https://doi.org/10.1016/S0959-8049(00)00137-4
  15. Chen LT, Chen CL, Hwang WS. The growing teratoma syndrome. A case of primary mediastinal nonseminomatous germ cell tumor treated with chemotherapy and radiotherapy. Chest 1990;98:231-233 https://doi.org/10.1378/chest.98.1.231
  16. Bahrami A, Ro JY, Ayala AG. An overview of testicular germ cell tumors. Arch Pathol Lab Med 2007;131:1267-1280 https://doi.org/10.5858/2007-131-1267-AOOTGC
  17. Inaoka T, Takahashi K, Yamada T, Miyokawa N, Tokusashi Y, Yoshida M, et al. The growing teratoma syndrome secondary to immature teratoma of the ovary. Eur Radiol 2003;13:2115-2118 https://doi.org/10.1007/s00330-002-1733-3
  18. Umekawa T, Tabata T, Tanida K, Yoshimura K, Sagawa N. Growing teratoma syndrome as an unusual cause of gliomatosis peritonei: a case report. Gynecol Oncol 2005;99:761-763
  19. Stomper PC, Kalish LA, Garnick MB, Richie JP, Kantoff PW. CT and pathologic predictive features of residual mass histologic findings after chemotherapy for nonseminomatous germ cell tumors: can residual malignancy or teratoma be excluded? Radiology 1991;180:711-714 https://doi.org/10.1148/radiology.180.3.1651526
  20. Panicek DM, Toner GC, Heelan RT, Bosl GJ. Nonseminomatous germ cell tumors: enlarging masses despite chemotherapy. Radiology 1990;175:499-502 https://doi.org/10.1148/radiology.175.2.2158120
  21. Miranda Ede P, Abe DK, Nesrallah AJ, dos Reis ST, Crippa A, Srougi M, et al. Predicting necrosis in residual mass analysis after retroperitoneal lymph node dissection: a retrospective study. World J Surg Oncol 2012;10:203
  22. Kattan J, Droz JP, Culine S, Duvillard P, Thiellet A, Peillon C. The growing teratoma syndrome: a woman with nonseminomatous germ cell tumor of the ovary. Gynecol Oncol 1993;49:395-399
  23. Han NY, Sung DJ, Park BJ, Kim MJ, Cho SB, Kim KA, et al. Imaging features of growing teratoma syndrome following a malignant ovarian germ cell tumor. J Comput Assist Tomogr 2014;38:551-557 https://doi.org/10.1097/RCT.0000000000000073
  24. Pfannenberg AC, Oechsle K, Bokemeyer C, Kollmannsberger C, Dohmen BM, Bares R, et al. The role of [18F] FDG-PET, CT/MRI and tumor marker kinetics in the evaluation of post chemotherapy residual masses in metastatic germ cell tumors--prospects for management. World J Urol 2004;22:132-139
  25. Aide N, Comoz F, Sevin E. Enlarging residual mass after treatment of a nonseminomatous germ cell tumor: growing teratoma syndrome or cancer recurrence? J Clin Oncol 2007;25:4494-4496 https://doi.org/10.1200/JCO.2007.12.7530
  26. Coscojuela P, Llauger J, Perez C, Germa J, Castaner E. The growing teratoma syndrome: radiologic findings in four cases. Eur J Radiol 1991;12:138-140 https://doi.org/10.1016/0720-048X(91)90116-D
  27. Lorigan JG, Eftekhari F, David CL, Shirkhoda A. The growing teratoma syndrome: an unusual manifestation of treated, nonseminomatous germ cell tumors of the testis. AJR Am J Roentgenol 1988;151:325-329 https://doi.org/10.2214/ajr.151.2.325
  28. Spiess PE, Kassouf W, Brown GA, Kamat AM, Liu P, Gomez JA, et al. Surgical management of growing teratoma syndrome: the M. D. Anderson cancer center experience. J Urol 2007;177:1330-1334
  29. Lee DJ, Djaladat H, Tadros NN, Movassaghi M, Tejura T, Duddalwar V, et al. Growing teratoma syndrome: clinical and radiographic characteristics. Int J Urol 2014;21:905-908 https://doi.org/10.1111/iju.12466
  30. Jeffery GM, Theaker JM, Lee AH, Blaquiere RM, Smart CJ, Mead GM. The growing teratoma syndrome. Br J Urol 1991;67:195-202 https://doi.org/10.1111/j.1464-410X.1991.tb15109.x